Table 3.
Histone modifier | Modification | MSC type | Target genes | Mechanism | Ref. |
---|---|---|---|---|---|
EHMT1 | Methylation | BMSC | RUNX2 | EHMT1 upregulated the H3K9me2 levels at the promoter of RUNX2, resulting in the repression of osteogenesis. | Huang et al. 102 |
ASH1L | Methylation | BMSC | OSX RUNX2 |
ASH1L-mediated H3K4me3 occurred at the promoter regions of OSX and RUNX2, ultimately promoting osteogenic differentiation. | Yin et al. 103 |
PRMT3 | Methylation | MSC | miR-3648 | PRMT3 activated the expression of miR-3648 by enhancing H4R3me2a levels at its promoter region, resulting in the promotion of osteogenic differentiation. | Min et al. 104 |
CARM1 | Methylation | BMSC | OCT4 SOX2 ANOG |
CARM1 was enriched on OCT4, SOX2, and NANOG promoter sites by enhancing di-methylation of H3R17 of these genes, resulting in the promotion of osteogenesis. | Jo et al. 105 |
LSD1 | Demethylation | BMSC | RUNX2 OCN |
LSD1 catalyzed the demethylation of di- and mono-methylation of H3K4 at RUNX2 and OCN promoter regions, resulting in the repression of osteogenic differentiation. | Lv et al. 106 |
LSD1 | Demethylation | ADSC | BMP2 SMAD4 |
Silencing of LSD1 promoted the osteoblastic potential by stimulating BMP2/SMAD4 signaling pathway. | Ma et al. 107 |
KDM1A | Demethylation | BMSC | circ_AFF4 FNDC5 |
KDM1A promoted circ_AFF4 and FNDC5 expression via reducing H3K9me3, thus inducing circ_AFF4 and FNDC5 expression and osteogenesis. | Liu et al. 108 |
GCN5 | Acetylation | ADSC | NF-κB | GCN5 repressed NF-κB-dependent transcription and inhibited the NF-κB signaling pathway, thus promoting osteogenic differentiation | Zhang et al. 109 |
HBO1 | Acetylation | ADSC | 14-3-3β | HBO1 suppressed the expression of 14-3-3β via increasing its acK49/51 acetylation, resulting in the promotion of osteogenic differentiation. | Frontini-López et al. 110 |
SIRT6 | Deacetylation | MSC | BMP2 BMP4 BMPR1A BMPR1B |
SIRT6 promoted osteogenic differentiation through BMP signaling pathway. | Zhang et al. 111 |
HDAC9 | Deacetylation | BMSC | pERK1/2 | Silencing of HDAC9 reduced the expression level of pERK1/2 and inhibited osteogenic differentiation. | Wang et al. 112 |